4 Years Safety of Fingolimod in Real World: PANGAEA a Non-Interventional Study of Safety, Effectiveness and Pharmacoeconomic is Data for Fingolimod Patients in Daily Clinical Practice

被引：0
|
作者：
Ziemssen, Tjalf [9 ]
Albrecht, Holger [3 ]
Haas, Judith [1 ]
Klotz, Luisa [8 ]
Lang, Michael [6 ]
Lassek, Chrstoph [2 ]
Schmidt, Stephan [5 ]
Tackenberg, Bjorn [7 ]
Cornelissen, Christian [4 ]
机构：
[1] Judisches Krankenhaus, Berlin, Germany
[2] Neurol Gemeinschaftspraxis, Kassel, Germany
[3] Neurol Praxis, Munich, Germany
[4] Novartis Pharma GmbH, Nurnberg, Germany
[5] NTD Study Grp, Bonn, Germany
[6] NTD Study Grp, Ulm, Germany
[7] Philipps Univ, Marburg, Germany
[8] Uniklin Munster, Munster, Germany
[9] Univ Clin Dresden, Dresden, Germany
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P2.077
引用
收藏
页数：2
相关论文
共 50 条
  • [1] 4 years safety of fingolimod in real world: PANGAEA, a non-interventional study of safety, effectiveness and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 416 - 416
  • [2] 4 Years PANGAEA: A 5-Year Non-Interventional Study of Safety, Effectiveness and Pharmacoeconomic Data for Fingolimod Patients in Daily Clinical Practice - Effectiveness Update
    Cornelissen, Christian
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Ziemssen, Tjalf
    NEUROLOGY, 2016, 86
  • [3] 4 years PANGAEA: A 5-year non-interventional study of safety, effectiveness and pharmacoeconomic data for fingolimod patients in daily clinical practice - effectiveness update
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 417 - 417
  • [4] 5 years safety of fingolimod in real world: First results from PANGAEA, a non-interventional study of RRMS patients treated with fingolimod, on safety and adherence after 5 years of fingolimod in daily clinical practice
    Ziemssen, Tjalf
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Cornelissen, Christian
    NEUROLOGY, 2017, 88
  • [5] 36 months PANGAEA: a 5-year non-interventional study of safety, efficacy and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 281 - 282
  • [6] 36 MONTHS PANGAEA: A 5-YEAR NON-INTERVENTIONAL STUDY OF SAFETY, EFFICACY AND PHARMACOECONOMIC DATA FOR FINGOLIMOD PATIENTS IN DAILY CLINICAL PRACTICE
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    VALUE IN HEALTH, 2015, 18 (07) : A749 - A749
  • [7] 5 years effectiveness of fingolimod in daily clinical practice: results of the non-interventional study PANGAEA
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 372 - 373
  • [8] 24 month PANGAEA: a 5-year non-interventional study of safety, efficacy and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Fuchs, A.
    Schwarz, H-J
    van Lokven, T.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 115 - 116
  • [9] 36 months PANGAEA: A 5-year non-interventional study of safety, efficacy and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Albrecht, H.
    Klotz, L.
    Schmidt, S.
    Schwarz, H. -J.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 28 - 28
  • [10] 36 months PANGAEA-A 5-year non-interventional study of safety, efficacy, and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L. Luisa
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP19 - NP20
12345